首页 | 本学科首页   官方微博 | 高级检索  
检索        

双苓扶正抗癌制剂对SGC-7901细胞增殖及c-myc基因表达的研究
引用本文:陈华圣,许爱华,贾玲昌,任 莉.双苓扶正抗癌制剂对SGC-7901细胞增殖及c-myc基因表达的研究[J].中国中药杂志,2006,31(21):1822-1824.
作者姓名:陈华圣  许爱华  贾玲昌  任 莉
作者单位:1. 扬州大学,医学院,江苏,扬州,225001
2. 扬州大学,临床医学院,江苏,扬州,225001
基金项目:江苏省科技厅社会发展基金
摘    要:目的:研究双苓扶正抗癌制剂对人胃癌细胞增殖及c-myc基因表达的影响。方法:采用MTT比色法,观察双苓扶正抗癌制剂(40~640 μg·mL-1)5个剂量组单用及其与阿霉素(0.4,4.0 μg·mL-1)及顺铂(0.1,1.0 μg·mL-1)分别合用在体外对人胃癌SGC-7901细胞增殖的抑制作用;采用流式细胞技术检测该制剂(80~320 μg·mL-1)对c-myc基因阳性蛋白标记率的影响。结果:双苓扶正抗癌制剂单用体外作用24 h,对人胃癌细胞增殖具有抑制作用,在40~640 μg·mL-1剂量下,其抑制率随剂量增加而增加;与阿霉素(0.4,4.0 μg·mL-1)或顺铂(0.1,1.0 μg·mL-1)分别合用,可提高对人胃癌细胞的抑制率;在80~320 μg·mL-1剂量下,可抑制c-myc基因的表达。结论:双苓扶正抗癌制剂单用对人胃癌细胞增殖具有抑制作用,且具有量效关系;与阿霉素或顺铂分别合用对人胃癌细胞的抑制作用具有协同效应;下调c-myc基因的表达可能是该制剂抑制肿瘤细胞增殖的作用机制之一。

关 键 词:双苓扶正抗癌制剂  SGC-7901细胞  c-myc基因  阿霉素  顺铂
文章编号:1001-5302(2006)21-1822-03
收稿时间:2006-02-10
修稿时间:2006-02-10

Study of Shuangling Fuzheng anti-tumor preparation on proliferation and c-myc gene expression of SGC-7901 cells
CHEN Hua-sheng ;XU Ai-hua;JIA Lin-chang;REN Li.Study of Shuangling Fuzheng anti-tumor preparation on proliferation and c-myc gene expression of SGC-7901 cells[J].China Journal of Chinese Materia Medica,2006,31(21):1822-1824.
Authors:CHEN Hua-sheng ;XU Ai-hua;JIA Lin-chang;REN Li
Institution:Medical College of Yangzhou University, Yangzhou 225001, China. hschen@yzu.edu.cn
Abstract:OBJECTIVE: To study the effect of Shuangling Fuzheng anti-tumor preparation (SLAP) five groups on proliferation and c-myc gene expression of SGC-7901 cells in vitro. METHOD: The inhibitory effect of single SLAP (40 -640 microg x mL(-1)) and combined therapy with adriamycin (0.4, 4.0 microg x mL(-1) or cisplatin (0.1,1.0 microg x mL(-1) on human gastric carcinoma SGC-7901 cells proliferation were observed by MTT colorimetric analysis method. Technique of flow cytometry in vitro was used to measure the rate of positive sign of SLAP (80 - 320 microg x mL(-1)) on c-myc gene protein of SGC-7901 cells. RESULT: SGC-7901 cells proliferation were inhibited by single SLAP in dose of 40 - 640 microg x mL(-1) 24 h. Its inhibitory rate was increased with increase of dose. The inhibitory rate on SGC-7901 cells could be increased by SLAP in dose of 40 - 640 microg x mL(-1) plus adriamycin in dose of 0.4 and 4.0 microg x mL(-1) or plus cisplatin in dose of 0.1 and 1.0 microg x mL(-1). At the same time, SLAP (80 - 320 microg x mL(-1)) also could inhibite the expression of c-myc gene of SGC -7901 cells. CONCLUSION: Single SLAP had inhibiting effect on human gastric carcinoma cells proliferation with a dose-effect relationship and synergic effect while combined with adriamycin or cisplatin. To inhibit the expression of c-myc gene of human gastric carcinoma cells might be one of action mechanisms of SLAP, which inhibited tumor cells proliferation.
Keywords:Shuangling Fuzheng anti-tumor preparation  SGC-7901 cells    c-myc gene  adriamycin  cisplatin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号